(FATE) Fate Therapeutics complete technical analysis [charts+indicators] | Buy/Sell Fate Therapeutics | (FATE) share price targets
Complete technical analysis of Fate Therapeutics (FATE) by charts plus indicators, forecast predictions and share price targets for Fate Therapeutics (FATE)
Fate Therapeutics trades in USA in Health Care sector.
Showing technical analysis as on 2024-10-10 View latest technical analysis
10 day averaged volume of Fate Therapeutics is 1199950
Date | Daily Closing Price | Open | High | Low | Volume |
10 Thu Oct 2024 | 2.94 | 2.96 | 2.97 | 2.85 | 0.866 times |
09 Wed Oct 2024 | 3.01 | 3.07 | 3.14 | 2.96 | 0.862 times |
08 Tue Oct 2024 | 3.07 | 3.04 | 3.15 | 2.98 | 1.434 times |
07 Mon Oct 2024 | 3.05 | 3.18 | 3.27 | 2.91 | 2.047 times |
04 Fri Oct 2024 | 3.22 | 3.23 | 3.35 | 3.16 | 0.779 times |
03 Thu Oct 2024 | 3.12 | 3.17 | 3.23 | 3.06 | 0.969 times |
02 Wed Oct 2024 | 3.21 | 3.28 | 3.32 | 3.15 | 0.93 times |
01 Tue Oct 2024 | 3.35 | 3.47 | 3.47 | 3.28 | 0.714 times |
30 Mon Sep 2024 | 3.50 | 3.59 | 3.80 | 3.48 | 1.013 times |
27 Fri Sep 2024 | 3.57 | 3.56 | 3.71 | 3.55 | 0.647 times |
My analysis of stock is bearish for shortterm, but trade for tomorrow is selective. Take a sell trade only if stock stays below 3.1, but if it comes above 3.1, then a intra day buy could be more profitable.
If you take a sell trade below 3.1, then use 3.1 as stoploss and 2.7 as target. However if you take a buy trade in stock , then use 3.1 as stoploss and 3.49 as target.
Share price targets for Fate Therapeutics (FATE)
Target Type | Value |
Downside Target | 2.85 |
Upside Target | 3.03 |
Upside Target | 3.20 |
Upside Target | 3.27 |
Upside Target | 3.47 |
Upside Target | 3.78 |
Upside Target | 3.90 |
Upside Target | 4.02 |
Upside Target | 4.19 |
Upside Target | 4.20 |
Upside Target | 5.49 |
Upside Target | 5.92 |
Intraday share price targets for Fate Therapeutics (FATE)
Target Type | Value |
Downside Intraday Target | 2.77 |
Downside Intraday Target | 2.6 |
Upside Intraday Target | 3.19 |
Upside Intraday Target | 3.44 |
Upside Intraday Target | 3.02 |
Weekly technical analysis of Fate Therapeutics (FATE)
Date | Weekly Closing Price | Open | High | Low | Volume |
10 Thu Oct 2024 | 2.94 | 3.18 | 3.27 | 2.85 | 1.182 times |
04 Fri Oct 2024 | 3.22 | 3.59 | 3.80 | 3.06 | 1.288 times |
27 Fri Sep 2024 | 3.57 | 3.90 | 3.90 | 3.38 | 0.624 times |
20 Fri Sep 2024 | 3.87 | 4.03 | 4.20 | 3.78 | 1.495 times |
13 Fri Sep 2024 | 4.02 | 3.40 | 4.02 | 3.35 | 1.107 times |
Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Fate Therapeutics (FATE)
Date | Monthly Closing Price | Open | High | Low | Volume |
10 Thu Oct 2024 | 2.94 | 3.47 | 3.47 | 2.85 | 0.509 times |
30 Mon Sep 2024 | 3.50 | 3.65 | 4.20 | 3.33 | 0.547 times |
30 Fri Aug 2024 | 3.67 | 5.35 | 5.49 | 3.20 | 0.814 times |
31 Wed Jul 2024 | 5.33 | 3.30 | 5.92 | 3.03 | 0.977 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Fate Therapeutics (FATE)
Price action analysis of Fate Therapeutics ( (FATE) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Fate Therapeutics ( (FATE) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Fate Therapeutics ( (FATE) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Fate Therapeutics ( (FATE) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Fate Therapeutics stock for short term is SELL. Signal strength is Weak and stock is gaining momentum.
MACD generated a SELL signal for Fate Therapeutics in short term and the sell signal is strong.
Fate Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Fate Therapeutics in short term and SELL signal is strong!
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Fate Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 3.17 and Fate Therapeutics (FATE) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Fate Therapeutics (FATE) stock. Volume based technical analysis of Fate Therapeutics (FATE) stock is negative.
Fate Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Fate Therapeutics ( (FATE) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Fate Therapeutics ( (FATE) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Fate Therapeutics ( (FATE) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Fate Therapeutics ( (FATE) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Fate Therapeutics stock for short term is SELL. Signal strength is Weak and stock is gaining momentum.
MACD generated a SELL signal for Fate Therapeutics in short term and the sell signal is strong.
Fate Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Fate Therapeutics in short term and SELL signal is strong!
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Fate Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 3.17 and Fate Therapeutics (FATE) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Fate Therapeutics (FATE) stock. Volume based technical analysis of Fate Therapeutics (FATE) stock is negative.
Fate Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.